Keywords: millennium, 3rd-qtr, loss, down, massachusetts, usa-based, biotechnology
Millennium's 3rd-qtr loss down 88%
Article | 21 November 2007
Massachusetts, USA-based biotechnology firm Millennium Pharmaceuticals reported a loss of $1.7 million for the third-quarter, 2007, an 87.7% reduction from the shortfall it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
